Updates on Trichodysplasia Spinulosa Disease

    April 2026 in “ Reviews in Medical Virology
    Luke Moore, Peter L. Rady, Stephen Tyring
    Studysummary This review discusses recent updates on trichodysplasia spinulosa, focusing on its seroepidemiology, mechanisms, and treatment options, and reports no new clinical results. Our plain-language summary of this paper — not a Tressless recommendation.
    Trichodysplasia spinulosa (TS) is a rare condition linked to immunosuppression, characterized by keratin spicules and potential progression to alopecia and a leonine face. Fewer than 100 cases have been documented, mostly in solid organ transplant patients. The infection mechanism of the causative Trichodysplasia spinulosa-associated polyomavirus (TSPyV) is not well understood, although 75% of adults have antibodies against it, and it is transiently present in about 1% of the population. Recent updates over the past 5 years include studies on the virus's seroepidemiology, proliferation mechanisms, and treatment options.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results